| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |